PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-256

  1. 54 Posts.
    lightbulb Created with Sketch. 46
    Not a bad idea, Mozz for CEO to inspire & sell the dream ... But, maybe Beaza79 or one of our other cautious but constructive cohort as Chairman to hold him to account and occasionally bring out the stick would be a better combination.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.